Remus Pharmaceuticals Limited (NSE:REMUS)

Remus Pharmaceuticals Statistics

Total Valuation

NSE:REMUS has a market cap or net worth of INR 10.97 billion. The enterprise value is 11.38 billion.

Market Cap	10.97B
Enterprise Value	11.38B

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

NSE:REMUS has 11.78 million shares outstanding. The number of shares has decreased by -21.35% in one year.

Current Share Class	11.78M
Shares Outstanding	11.78M
Shares Change (YoY)	-21.35%
Shares Change (QoQ)	-48.68%
Owned by Insiders (%)	51.36%
Owned by Institutions (%)	n/a
Float	5.62M

Valuation Ratios

The trailing PE ratio is 28.54.

PE Ratio	28.54
Forward PE	n/a
PS Ratio	1.77
PB Ratio	3.88
P/TBV Ratio	4.44
P/FCF Ratio	n/a
P/OCF Ratio	157.13
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 24.91, with an EV/FCF ratio of -274.94.

EV / Earnings	39.16
EV / Sales	1.83
EV / EBITDA	24.91
EV / EBIT	25.98
EV / FCF	-274.94

Financial Position

The company has a current ratio of 1.82, with a Debt / Equity ratio of 0.08.

Current Ratio	1.82
Quick Ratio	0.96
Debt / Equity	0.08
Debt / EBITDA	0.50
Debt / FCF	-5.55
Interest Coverage	30.01

Financial Efficiency

Return on equity (ROE) is 19.86% and return on invested capital (ROIC) is 13.00%.

Return on Equity (ROE)	19.86%
Return on Assets (ROA)	7.94%
Return on Invested Capital (ROIC)	13.00%
Return on Capital Employed (ROCE)	14.09%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	48
Asset Turnover	1.80
Inventory Turnover	11.28

Taxes

In the past 12 months, NSE:REMUS has paid 89.20 million in taxes.

Income Tax	89.20M
Effective Tax Rate	18.84%

Stock Price Statistics

The stock price has decreased by -14.84% in the last 52 weeks. The beta is 0.68, so NSE:REMUS's price volatility has been lower than the market average.

Beta (5Y)	0.68
52-Week Price Change	-14.84%
50-Day Moving Average	972.27
200-Day Moving Average	1,105.84
Relative Strength Index (RSI)	47.32
Average Volume (20 Days)	7,345

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:REMUS had revenue of INR 6.20 billion and earned 290.70 million in profits. Earnings per share was 32.61.

Revenue	6.20B
Gross Profit	874.90M
Operating Income	438.20M
Pretax Income	473.40M
Net Income	290.70M
EBITDA	456.90M
EBIT	438.20M
Earnings Per Share (EPS)	32.61

Balance Sheet

The company has 81.40 million in cash and 229.80 million in debt, giving a net cash position of -148.40 million or -12.59 per share.

Cash & Cash Equivalents	81.40M
Total Debt	229.80M
Net Cash	-148.40M
Net Cash Per Share	-12.59
Equity (Book Value)	2.83B
Book Value Per Share	423.08
Working Capital	998.40M

Cash Flow

In the last 12 months, operating cash flow was 69.80 million and capital expenditures -111.20 million, giving a free cash flow of -41.40 million.

Operating Cash Flow	69.80M
Capital Expenditures	-111.20M
Free Cash Flow	-41.40M
FCF Per Share	-3.51

Margins

Gross margin is 14.10%, with operating and profit margins of 7.06% and 4.69%.

Gross Margin	14.10%
Operating Margin	7.06%
Pretax Margin	7.63%
Profit Margin	4.69%
EBITDA Margin	7.37%
EBIT Margin	7.06%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.75, which amounts to a dividend yield of 0.08%.

Dividend Per Share	0.75
Dividend Yield	0.08%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	4.06%
Buyback Yield	21.35%
Shareholder Yield	21.44%
Earnings Yield	2.65%
FCF Yield	-0.38%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 4, 2025. It was a forward split with a ratio of 2.

Last Split Date	Jul 4, 2025
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	5